We are live on
!
Find out more
US Bancorp Portfolio holdings
AUM
$82.4B
1-Year Est. Return
19.69%
This Fund
S&P 500
This Quarter
Est. Return
+8.01%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$39.1B
AUM Growth
+$2.42B
(+6.6%)
Cap. Flow
-$248M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
22.64%
Holding
3,845
New
218
Increased
1,110
Reduced
1,483
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell Mid-Cap ETF
IWR
|
+$45.6M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$40.7M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$38.8M |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$35.5M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$34.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$80.2M |
| 2 |
Copart
CPRT
|
+$55.9M |
| 3 |
US Bancorp
USB
|
+$47.8M |
| 4 |
IBDK
iShares iBonds Dec 2019 Term Corporate ETF
IBDK
|
+$25.8M |
| 5 |
iShares Floating Rate Bond ETF
FLOT
|
+$17.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.27% |
| 2 | Financials | 10.78% |
| 3 | Industrials | 9.91% |
| 4 | Healthcare | 9.19% |
| 5 | Consumer Staples | 6.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Nordson
NDSN
$16.5B
| $1.14M | ﹤0.01% |
6,994
-15
| -0.2% | -$2.37K |
|
1002
Omnicell
OMCL
$1.86B
| $1.13M | ﹤0.01% |
13,870
-902
| -6% | -$69.2K |
|
1003
Host Hotels & Resorts
HST
$16.8B
| $1.13M | ﹤0.01% |
60,964
-15,129
| -20% | -$262K |
|
|
AAN.A
1004
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $1.13M | ﹤0.01% |
19,828
+1,125
| +6% | +$64.2K |
|
1005
Progress Software
PRGS
$1.55B
| $1.13M | ﹤0.01% |
27,169
+1,651
| +6% | +$67.1K |
|
|
SNV
1006
DELISTED
Synovus
SNV
| $1.13M | ﹤0.01% |
28,795
+2,348
| +9% | +$86.3K |
|
1007
JD.com
JD
$40.8B
| $1.12M | ﹤0.01% |
31,829
+1,737
| +6% | +$56K |
|
1008
iShares Core MSCI Pacific ETF
IPAC
$2.6B
| $1.11M | ﹤0.01% |
19,089
-4,035
| -17% | -$234K |
|
1009
STAG Industrial
STAG
$7.86B
| $1.11M | ﹤0.01% |
35,305
+4,019
| +13% | +$123K |
|
1010
Oxford Industries
OXM
$577M
| $1.11M | ﹤0.01% |
14,754
+833
| +6% | +$60.2K |
|
1011
Freeport-McMoran
FCX
$90B
| $1.11M | ﹤0.01% |
84,612
+2,284
| +3% | +$25.1K |
|
1012
Franklin Electric
FELE
$4.67B
| $1.11M | ﹤0.01% |
19,357
+125
| +0.6% | +$6.6K |
|
|
PTLA
1013
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $1.11M | ﹤0.01% |
46,508
-90
| -0.2% | -$2.48K |
|
1014
State Street SPDR Bloomberg International Treasury Bond ETF
BWX
$1.32B
| $1.11M | ﹤0.01% |
38,370
-8,879
| -19% | -$254K |
|
1015
iShares MSCI Pacific ex Japan ETF
EPP
$2.18B
| $1.11M | ﹤0.01% |
23,882
-404
| -2% | -$18.5K |
|
1016
BCE
BCE
$19.9B
| $1.1M | ﹤0.01% |
23,829
+856
| +4% | +$41K |
|
|
EV
1017
DELISTED
Eaton Vance Corp.
EV
| $1.1M | ﹤0.01% |
23,610
-1,389
| -6% | -$64.2K |
|
1018
Arrow Electronics
ARW
$10.9B
| $1.1M | ﹤0.01% |
12,953
+42
| +0.3% | +$3.34K |
|
1019
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$50.7B
| $1.1M | ﹤0.01% |
26,201
-1,018
| -4% | -$40.8K |
|
1020
Wyndham Hotels & Resorts
WH
$5.46B
| $1.1M | ﹤0.01% |
17,490
-10,506
| -38% | -$584K |
|
1021
Cadence Design Systems
CDNS
$90B
| $1.1M | ﹤0.01% |
15,816
+6,781
| +75% | +$455K |
|
1022
Loews
L
$24.3B
| $1.1M | ﹤0.01% |
20,898
+3,895
| +23% | +$197K |
|
1023
Devon Energy
DVN
$51.9B
| $1.1M | ﹤0.01% |
42,191
-3,266
| -7% | -$73.5K |
|
1024
Western Union
WU
$2.57B
| $1.09M | ﹤0.01% |
40,738
+480
| +1% | +$12.4K |
|
|
CMA
1025
DELISTED
Comerica
CMA
| $1.09M | ﹤0.01% |
15,147
-1,115
| -7% | -$76.5K |
|
Similar funds
US Bancorp's Q4 2019 Portfolio in Review
As of Q4 2019, US Bancorp held 3,845 positions worth $39.1B, up 6.6% from $36.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
US Bancorp's Q4 2019 filing shows 218 new, 1,110 increased, 1,483 reduced and 148 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M. The largest sale was Celgene Corp, an estimated $80.2M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
- US Bancorp's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M.
- US Bancorp added most to iShares Russell Mid-Cap ETF in Q4 2019, an estimated $45.6M increase.
- US Bancorp's biggest Q4 2019 reduction was Copart, cutting an estimated $55.9M.
- US Bancorp fully exited Celgene Corp in Q4 2019, selling an estimated $80.2M.
- US Bancorp's ten largest holdings make up 23% of its $39.1B portfolio in Q4 2019.
- US Bancorp opened 218 new positions and closed 148 in Q4 2019.
- US Bancorp's portfolio value rose 6.6% quarter-over-quarter to $39.1B.
Based on US Bancorp's 13F filing for Q4 2019, filed 4 Feb 2020.